The Food and Drug Administration rejected Moderna's new flu shot. This raises questions about what it means for the future of vaccine development.

America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. The U.S. federal government has moved to cut millions of dollars in funding for mRNA vaccine ...

Add Yahoo as a preferred source to see more of our stories on Google. UNITED STATES - AUGUST 4: HHS Secretary Robert F. Kennedy Jr., speaks at an event where Secretary of Agriculture Brooke Rollins ...

So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and treatments against a long ...

Moderna noted the FDA did not identify any specific safety concerns with the vaccine and that the rejection was inconsistent with previous feedback.

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...

Some genetic mutations that are expected to completely stop a gene from working surprisingly cause only mild or even no symptoms. Researchers in previous studies have discovered one reason why: cells ...

The Food and Drug Administration on Wednesday defended its rejection of Moderna’s mRNA-based flu vaccine application, saying the company’s clinical trial design put patients at risk ...